BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:“Attenuating oncogenic transcription with small molecules”
DTSTART:20210527T160000
DTEND:20210527T173000
DTSTAMP:20260510T135105Z
UID:4c9e8a0a008144fed11e7a35bca490548b0f1277711d1e9dd9fc7525
CATEGORIES:Conferences - Seminars
DESCRIPTION:Angela KOEHLER\, Goldblith Career Development Professor in App
 lied Biology\, Department of Biological Engineering\, MIT\nKoch Institute 
 for Integrative Cancer Research\, MIT\, Institute Member\, Board Institute
  of MIT and Harvard\, MIT Center for Precision Cancer Medicine\nCambridge 
 - USA  Koehler Lab\nA Lola and John Grace Distinguished Lecture in Cancer
  Research\n\nAngela received her B.A. in Biochemistry and Molecular Biolog
 y from Reed College in 1997. There she worked under the guidance of Profes
 sor Arthur Glasfeld on structural and biochemical studies of proteins that
  recognize tRNA or DNA. In 2003\, she received her PhD in Chemistry from H
 arvard University where she worked with Professor Stuart Schreiber to deve
 lop novel technologies for identifying and characterizing interactions bet
 ween proteins and small molecules. Upon graduation\, she became an Institu
 te Fellow in the Chemical Biology Program at the Broad Institute and a Gro
 up Leader for the NCI Initiative for Chemical Genetics. She is also a Proj
 ect Leader in the NCI Cancer Target Discovery and Development (CTD2) Cente
 r at the Broad Institute aimed at targeting causal cancer genes with small
  molecules.\n \nThe Koehler lab is focused on building chemical tools and
  methods for studying temporal aspects of transcriptional regulation in de
 velopment and disease with a focus on cancer. The lab pursues these goals 
 by discovering and developing direct small-molecule probes of proteins inv
 olved in transcriptional regulation such as transcription factors and c
 hromatin modifying enzymes.\n\n 
LOCATION:https://epfl.zoom.us/s/97039045251
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR